INNPF News and Press, Innovative Properties Inc From 09/21/23

NOT FOR DISSEMINATION IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HERZLIYA, Israel and CALGARY, Alberta, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Innocan Pharma Corporation (the “ Company ”) (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to ann...

Innocan Pharma Announces the Addition of Dr. Joseph V. Pergolizzi, Jr., M.D. to its Advisory Board Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Sept. 15, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "I...

Innocan Pharma Announces Promising Results from Hair Care Cream Efficacy Test Canada NewsWire Innocan hair care cream efficacy trial observes enhanced hair growth in male and female participants in a 14day period. 91 % of participants reported stronger hair and 100% ...

2023-09-01 11:40:00 ET Delta, Kelowna, BC - September 1, 2023 (Investorideas.com Newswire) investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today's podcast edition of cannabis news and stocks to watch plus ...

Innocan Pharma Announces Clinical Study Results: Evidence of Reduced Osteoarthritis Pain in Dogs After Liposomal CBD Injection Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Aug. 29, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OT...

Innocan Pharma Reports Q2 2023 Results Including US$2.706M Increase in Revenues Compared to Q2, 2022 Canada NewsWire US$3.121M Revenues for Q2, 2023 compared to US$415,000 for Q2 2022, representing an increase of 652% US$2.656M Gross Profit for Q2, 2023 compare...

Innocan Pharma Announces Promising Successful Results in Efficacy Trial of Diabetic Foot Relief Treatment Canada NewsWire HERZLIYA, Israel and CALGARY, AB , Aug. 15, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Com...

Innocan Pharma Unveils Groundbreaking Veterinary Breakthroughs at EAVPT 2023 Congress Canada NewsWire HERZLIYA, Israel and CALGARY, AB , June 22, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF), a leading innovator in pharmaceut...

Innocan Pharma Reports Q1 2023 Results including US$1.3M Increase in Revenues Compared to Q1 2022 Canada NewsWire USD 1.4M Gross Profit, compared to USD 78K last year USD 4.1M Cash Balance along the entire corporate structure USD 1.3M Increase in Revenu...

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - December 2, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to anno...